NSETrading Window14h ago · 25 Sept 2026, 08:57 pm

Trading Window

Gaudium IVF and Women Health Limited · GAUDIUMIVF

✦ AI SummaryRegulatory

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk3/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gaudium IVF and Women Health Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

GAUDIUM_25092026205625_Trading_Window_Closure.pdf

pdf

Download →
View document text
gaudium® IVF Delivering Motherhood Dreams September 25, 2026 To, To, The Listing Department, The Listing Department, BSE Limited, National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai - 400001 Mumbai - 400051 Scrip Code - 544709 Symbol - GAUDIUMIVF ISIN: INEOP8B01020 ISIN: INEOP8B01020 Subject: Intimation for Closure of Trading Window Dear Sir/Ma’am, This is to inform you that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, including amendments, if any, and as per the Company’s “Code of conduct to regulate, monitor and report trading by Designated Persons and their immediate relatives ("Code”) and Code of practices and procedures for fair disclosure of unpublished price sensitive information (“Fair Disclosure Code”), the trading window for dealing in the securities of the Company shall remain closed for the designated persons and their immediate relatives from Thursday, October 01, 2026 till the expiry of 48 (forty eight) hours after the announcement of unaudited standalone and consolidated financial results of the Company for the quarter and half year ending September 30, 2026. The date of the meeting of the Board of Directors of the Company inter alia, to approve the financial results of the Company for the aforesaid period will be intimated separately in due course of time. The above is for information and records. Thanking you, Yours faithfully, For and on behalf of Gaudium IVF and Women Health Limited (Formerly Known as Gaudium IVF and Women Health Private Limited) Naveen Kumar Company Secretary and Compliance Officer Membership No: A69788 Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.) Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585 CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com Elig2E[E]